ProShare Advisors LLC lowered its position in DexCom, Inc. (NASDAQ:DXCM – Get Rating) by 10.6% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 348,544 shares of the medical device company’s stock after selling 41,329 shares during the period. ProShare Advisors LLC’s […]
An artificial pancreas developed at the University of Virginia Center for Diabetes Technology improves blood sugar control for people ages 2 to 72 with type 1 diabetes, according to a new combined analysis of three clinical trials.
Weekly Upgrades and Downgrades | InvestorPlace investorplace.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investorplace.com Daily Mail and Mail on Sunday newspapers.
The healthcare sector has been looking fit in the past month, with medical products makers Stryker Corp. (NYSE: SYK) and Boston Scientific Corp. (NYSE: BSX)…
Medicare patients using all types of insulin now have coverage for Dexcom G7 – giving approximately 1.5 million more Americans access to the most accurate,1 simple to use1 CGM at the same. | April 17, 2023